338 related articles for article (PubMed ID: 11078210)
41. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy.
Kimura S; Ikezawa M; Nomura K; Ito K; Ozasa S; Ueno H; Yoshioka K; Yano S; Yamashita T; Matuskura M; Miike T
Brain Dev; 2006 Aug; 28(7):473-6. PubMed ID: 16516424
[TBL] [Abstract][Full Text] [Related]
42. Immunoproteasome in animal models of Duchenne muscular dystrophy.
Chen CN; Graber TG; Bratten WM; Ferrington DA; Thompson LV
J Muscle Res Cell Motil; 2014 Apr; 35(2):191-201. PubMed ID: 24934129
[TBL] [Abstract][Full Text] [Related]
43. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
[TBL] [Abstract][Full Text] [Related]
44. [Proteasomes. Complex proteases lead to a new understanding of cellular regulation through proteolysis].
Hilt W; Wolf DH
Naturwissenschaften; 1995 Jun; 82(6):257-68. PubMed ID: 7643904
[TBL] [Abstract][Full Text] [Related]
45. [Clinical significance of dystrophin positive fibers in Duchenne muscular dystrophy].
Chuang YH; Jong YJ; Liu KM; Chen SS
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):409-15. PubMed ID: 7650780
[TBL] [Abstract][Full Text] [Related]
46. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
Attaix D; Aurousseau E; Combaret L; Kee A; Larbaud D; Rallière C; Souweine B; Taillandier D; Tilignac T
Reprod Nutr Dev; 1998; 38(2):153-65. PubMed ID: 9638789
[TBL] [Abstract][Full Text] [Related]
47. A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
Beekman C; Sipkens JA; Testerink J; Giannakopoulos S; Kreuger D; van Deutekom JC; Campion GV; de Kimpe SJ; Lourbakos A
PLoS One; 2014; 9(9):e107494. PubMed ID: 25244123
[TBL] [Abstract][Full Text] [Related]
48. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH
J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
[TBL] [Abstract][Full Text] [Related]
49. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes.
Mitch WE; Medina R; Grieber S; May RC; England BK; Price SR; Bailey JL; Goldberg AL
J Clin Invest; 1994 May; 93(5):2127-33. PubMed ID: 8182144
[TBL] [Abstract][Full Text] [Related]
50. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
[TBL] [Abstract][Full Text] [Related]
51. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
Spuler S; Engel AG
Neurology; 1998 Jan; 50(1):41-6. PubMed ID: 9443455
[TBL] [Abstract][Full Text] [Related]
52. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
53. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
54. Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course.
Fanin M; Danieli GA; Cadaldini M; Miorin M; Vitiello L; Angelini C
Muscle Nerve; 1995 Oct; 18(10):1115-20. PubMed ID: 7659105
[TBL] [Abstract][Full Text] [Related]
55. Autosomal recessive distal muscular dystrophy: normal expression of dystrophin, utrophin and dystrophin-associated proteins in muscle fibers.
Yamanouchi Y; Ozawa E; Nonaka I
J Neurol Sci; 1994 Oct; 126(1):70-6. PubMed ID: 7836950
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical study of clathrin in distal myopathy with rimmed vacuoles.
Kumamoto T; Abe T; Nagao S; Ueyama H; Tsuda T
Acta Neuropathol; 1998 Jun; 95(6):571-5. PubMed ID: 9650748
[TBL] [Abstract][Full Text] [Related]
57. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
58. Dissociation of SH3 and cysteine-rich domain 3 and junctophilin 1 from dihydropyridine receptor in dystrophin-deficient muscles.
Ashida Y; Himori K; Tokuda N; Naito A; Yamauchi N; Takenaka-Ninagawa N; Aoki Y; Sakurai H; Yamada T
Am J Physiol Cell Physiol; 2022 Sep; 323(3):C885-C895. PubMed ID: 35912995
[TBL] [Abstract][Full Text] [Related]
59. Increased dysferlin expression in Duchenne muscular dystrophy.
Vontzalidis A; Terzis G; Manta P
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
[TBL] [Abstract][Full Text] [Related]
60. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
